Language

Global Precision Oncology In-Depth Monitoring and Development Analysis Report 2024

Length- 128 Pages | Published Date - 2024-04-15 | Report Id- 15193
Single Licence $3850.00 | Enterprise License $6200.00 | Multiple Licensee $6200.00
Description Table of Contents Table of Figures
The global Precision Oncology market size in 2023 is 110016.0 million US dollars, and it is expected to be 213708.8 million US dollars by 2030, with a compound annual growth rate of 10.0% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Precision Oncology market include Thermo Fisher Scientific, Inc., Invitae Corporation, Illumina, Inc., Myriad Genetics, Inc., and AstraZeneca. The share of the top 3 players in the Precision Oncology market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Precision Oncology market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Breast cancer accounted for XX% of Precision Oncology market in 2023. Colorectal cancer share of XX%.
Pharmaceutical & Biotechnology Companies accounted for XX% of the Precision Oncology market in 2023. Hospitals & Diagnostic Laboratories accounts for XX%.

This Precision Oncology market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

Precision Oncology market country level analysis
The countries covered in the Precision Oncology market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and Precision Oncology Market Share Analysis
Precision Oncology market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Precision Oncology market.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapters 2-7: Provide Global, North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Precision Oncology market type, application, player and country market segmentation data.
Chapters 8-9: Segmented the global Precision Oncology market by type, and application. Analyze the revenue of market segments from different perspectives.
Chapter 10: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 11: Analyzes the main companies in the Precision Oncology industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapter 12: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
South America
Brazil
Argentina
Colombia
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
Thermo Fisher Scientific, Inc.
Invitae Corporation
Illumina, Inc.
Myriad Genetics, Inc.
AstraZeneca
Rain Oncology Inc.
Strata Oncology, Inc.
Repare Therapeutics
Relay Therapeutics
Exscientia
Exact Sciences Corporation

Types list
Breast cancer
Colorectal cancer
Lung cancer
Blood Cancer
Prostate Cancer
Others

Application list
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Healthcare Data Companies

Contact US Anytime

Contact US Anytime

Find More

Global Precision Oncology In-Depth Monitoring and Development Analysis Report 2024

Get a FREE sample

Have Requests? Need Customization? Our Research Team Will Help to Maximize Your "Interest Scope and Content Customization" into Our Analysis Report.

Custom Research
Dongguan Jianpeng Intelligent Technology Co., Ltd
top

Phone Number +86 195 30455980

Research Consulting reports@arstaresearch.com

Business Cooperation sales@arstaresearch.com

Copyright © 2020-2025 Arsta Research All Rights Reserved
Technical support : Cssl
Choose a different language
╳
English Español‎ Português Français Deutsch Русский Suomen Kieli Myanmar Tiếng Việt にほんご 한국어 Italiana हिन्दी Melayu ภาษาไทย اللغة العربية 中文(简体) 中文(繁体)

Sample Request

Message